Impact of neuroprotective therapy on cognition and oxidative stress in the early stages of Parkinson’s disease
The aim of this study was to investigate the clinical and biochemical efficiency of citicoline in cognitive improvement and changes of glutathione peroxidase (GPx) blood plasma levels in patients at early stages of Parkinson’s disease (PD). Materials and methods. We recruited 42 patients at I–II...
Saved in:
| Main Authors: | A. V. Demchenko, V. V. Biriuk |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2021-12-01
|
| Series: | Patologìâ |
| Subjects: | |
| Online Access: | http://pat.zsmu.edu.ua/article/view/247142/246806 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Psychoemotional and cognitive characteristics in patients at the early stages of Parkinson’s disease
by: A. V. Demchenko, et al.
Published: (2020-04-01) -
A modern view on potential biomarkers of Parkinson’s disease (review)
by: A. V. Demchenko, et al.
Published: (2020-08-01) -
The activity of markers of oxidative and nitrosative stresses in blood plasma of Parkinson’s disease patients at the early stages
by: A. V. Demchenko, et al.
Published: (2021-09-01) -
A prospective study of cognitive impairment in Parkinson’s disease: clinical, neuropsychological, and neuroimaging correlates
by: Ahmed A. Gaballa, et al.
Published: (2025-06-01) -
Cognitive impairment in patients with Parkinson’s disease
by: I. A. Zhukova, et al.
Published: (2010-08-01)